Related Experiment Video
Updated: May 1, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.2K
[Future prospects for hepatitis C treatment: without interferon and ribavirin?]
1Servicio de Hepatología, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, España.
Gastroenterologia Y Hepatologia
|April 1, 2014
Summary
Hepatitis C treatment is evolving. New interferon-free therapies offer improved safety and efficacy for chronic hepatitis C, especially for patients with cirrhosis or prior treatment failure.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Context:
- Chronic hepatitis C virus (HCV) infection remains a significant global health concern.
- Current standard treatment for genotype 1 HCV involves pegylated interferon, ribavirin, and first-generation protease inhibitors (telaprevir or boceprevir).
- This triple therapy, while effective, presents challenges including increased complexity, cost, and adverse effects like hematological and cutaneous issues.
Purpose:
- To review the current treatment landscape for chronic hepatitis C.
- To discuss the efficacy and safety of emerging interferon-free direct antiviral agent (DAA) combinations.
- To highlight the need for patient selection for optimal treatment outcomes.
Summary:
- Triple therapy for chronic hepatitis C has limitations, particularly in patients with cirrhosis or null response, due to suboptimal viral response rates and significant adverse events.
- Interferon-free DAA combinations demonstrate high safety and tolerability as first-line treatments.
- Ongoing research focuses on the clinical application and accessibility of these novel DAA regimens.
Impact:
- Improved patient outcomes through safer and more effective hepatitis C treatment regimens.
- Potential for reduced healthcare burden associated with managing chronic hepatitis C complications.
- Advancement in the development of curative strategies for hepatitis C virus infection.
Keywords:
Antiviral therapyAntivirales directosDirect antiviral agentsHepatitis CLiver transplantationTrasplante hepáticoTratamiento antiviralTriple terapiaTriple therapyMore Related Videos
Related Concept Videos
01:25Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
01:28Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:10Retrovirus Life Cycles
43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
01:16Hepatic Drug Excretion: Influencing Factors
818
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
818